February 15, 2017
Weil advised SoftBank Group Corp. (“SoftBank”), a leading, diversified Japanese public company, in its pending $3.3 billion acquisition of Fortress Investment Group LLC (“Fortress”), an alternative asset manager with $70.1 billion in assets under management. Fortress will operate within SoftBank as an independent business headquartered in New York. The transaction is expected to close in the second half of 2017 and is subject to customary closing conditions.
The Weil team advising SoftBank is led by Private Equity partner Harvey Eisenberg and Mergers & Acquisitions partner James Griffin and includes Executive Compensation & Benefits partners Michael Nissan and Sarah Downie; Tax Partners Mark Schwed, Jared Rusman and Jonathan Macke; Private Funds partner Stephanie Srulowitz; Private Funds Regulatory partner David Wohl; Banking & Finance partner Andrew Colao; Structured Finance & Derivatives partner Robert Chiperfield; Head of Financial Institutions Regulatory Derrick Cephas; Securities Litigation partners Greg Danilow and Paul Dutka; International Arbitration & Trade partner Ted Posner; Private Equity counsel Ryan Taylor; Private Funds counsel Venera Ziegler; Antitrust counsel Vadim Brusser; Regulatory counsel Adam Safwat; Corporate associates Ryan Gorsche, Benjamin Adelson, Alexander Miachika, Clayton Collett, Daniel Waxman, Timothy Ormsby, Timothy Burns (Not Yet Admitted in New York) and Andrew Jacob (Not Yet Admitted in New York); Executive Compensation & Benefits associates Paula Han, Corinne Nhaissi and John Kleinjan (Not Yet Admitted in New York); Tax associates Joseph Reich and Soo Jin Kim (Not Yet Admitted in New York); Private Funds associates Cassie Kimmelman, Marc Schubert, Carley Groobman, Gregory Denis, Matthew Merritt and Nathan Atkins (Not Yet Admitted in New York); Banking & Finance associates Banks Bruce and Alice Pang; Structured Finance & Derivatives associates Shawn Kodes and Matthew Nemeth; Antitrust associate Jonathan Cheng; Securities Litigation associate Sean Moloney; and Regulatory associates Timothy Welch and Cecile Farmer.